Product Code: ETC8274968 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Central Nervous System Therapeutic Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Central Nervous System Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Central Nervous System Therapeutic Market - Industry Life Cycle |
3.4 Mexico Central Nervous System Therapeutic Market - Porter's Five Forces |
3.5 Mexico Central Nervous System Therapeutic Market Revenues & Volume Share, By Disease, 2021 & 2031F |
4 Mexico Central Nervous System Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Mexico |
4.2.2 Rising awareness about mental health and neurological conditions |
4.2.3 Growing research and development activities in the CNS therapeutic market |
4.3 Market Restraints |
4.3.1 Limited access to advanced CNS therapies in certain regions of Mexico |
4.3.2 Stringent regulatory requirements for drug approvals in the CNS therapeutic market |
4.3.3 High cost associated with CNS medications and treatments |
5 Mexico Central Nervous System Therapeutic Market Trends |
6 Mexico Central Nervous System Therapeutic Market, By Types |
6.1 Mexico Central Nervous System Therapeutic Market, By Disease |
6.1.1 Overview and Analysis |
6.1.2 Mexico Central Nervous System Therapeutic Market Revenues & Volume, By Disease, 2021- 2031F |
6.1.3 Mexico Central Nervous System Therapeutic Market Revenues & Volume, By Neurovascular Diseases, 2021- 2031F |
6.1.4 Mexico Central Nervous System Therapeutic Market Revenues & Volume, By CNS Trauma, 2021- 2031F |
6.1.5 Mexico Central Nervous System Therapeutic Market Revenues & Volume, By Mental Health, 2021- 2031F |
6.1.6 Mexico Central Nervous System Therapeutic Market Revenues & Volume, By Neurodegenerative Diseases, 2021- 2031F |
6.1.7 Mexico Central Nervous System Therapeutic Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.1.8 Mexico Central Nervous System Therapeutic Market Revenues & Volume, By CNS Cancer, 2021- 2031F |
7 Mexico Central Nervous System Therapeutic Market Import-Export Trade Statistics |
7.1 Mexico Central Nervous System Therapeutic Market Export to Major Countries |
7.2 Mexico Central Nervous System Therapeutic Market Imports from Major Countries |
8 Mexico Central Nervous System Therapeutic Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for CNS therapies |
8.2 Adoption rate of innovative CNS therapeutic solutions |
8.3 Number of partnerships and collaborations in the CNS therapeutic market |
8.4 Rate of successful drug approvals for CNS treatments |
8.5 Investment in CNS research and development in Mexico |
9 Mexico Central Nervous System Therapeutic Market - Opportunity Assessment |
9.1 Mexico Central Nervous System Therapeutic Market Opportunity Assessment, By Disease, 2021 & 2031F |
10 Mexico Central Nervous System Therapeutic Market - Competitive Landscape |
10.1 Mexico Central Nervous System Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Mexico Central Nervous System Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |